Details for New Drug Application (NDA): 201828
✉ Email this page to a colleague
NDA 201828 describes NORGESTREL AND ETHINYL ESTRADIOL, which is a drug marketed by Mylan Labs Ltd and is included in two NDAs. Additional details are available on the NORGESTREL AND ETHINYL ESTRADIOL profile page.
The generic ingredient in NORGESTREL AND ETHINYL ESTRADIOL is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
The generic ingredient in NORGESTREL AND ETHINYL ESTRADIOL is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
Summary for 201828
| Tradename: | NORGESTREL AND ETHINYL ESTRADIOL |
| Applicant: | Mylan Labs Ltd |
| Ingredient: | ethinyl estradiol; norgestrel |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-28 | Strength | 0.03MG;0.3MG | ||||
| Approval Date: | Jun 21, 2016 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
